Rectal concentrations of thioguanine after enema administratio
Phase 1
- Conditions
- Oral and gastrointestinalOral and Gastrointestinal - Inflammatory bowel disease
- Registration Number
- ACTRN12622000934741
- Lead Sponsor
- Douglas Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Patients previously treated with Pentasa/thioguanine enemas for proctitis
Exclusion Criteria
Unable to provide informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method